Are you Dr. Addo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 81 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-726-3812Fax+1 617-724-8586
Summary
- Dr. Marylyn Addo, MD is an infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Assistant Professor of Medicine at Massachusetts General Hospital.
Education & Training
- Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2006 - 2008
- Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2006
- University of Bonn Faculty of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2008 - 2015
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Safety, Tolerability and Immunogenicity of Vaccine Candidate MVA-MERS-S Start of enrollment: 2017 Nov 28
- Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS Start of enrollment: 2021 Apr 16
Publications & Presentations
PubMed
- 2 citationsSafety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo...Matthijs P Raadsen, Christine Dahlke, Anahita Fathi, Svenja Hardtke, Michael Klüver
The Lancet. Infectious Diseases. 2024-10-07 - 2 citationsMVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.Leonie Mayer, Leonie M Weskamm, Anahita Fathi, Maya Kono, Jasmin Heidepriem
NPJ Vaccines. 2024-01-26 - 8 citationsIncreased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.Anahita Fathi, Christine Dahlke, Verena Krähling, Alexandra Kupke, Nisreen M A Okba
Nature Communications. 2022-07-19
Press Mentions
- Modern Medicine, a Variety of JobsMay 17th, 2023
- Vaccine Hammer in Germany: AstraZeneca Not Approved for Older People – Spahn and RKI Boss Live NOWJanuary 29th, 2021
- Vaccine Effects in Danger? Karl Lauterbach Is Concerned – Mutation from South Africa “Super Dangerous”January 29th, 2021
- Join now to see all